v3.25.2
Fair Value Measurements
6 Months Ended
Jun. 30, 2025
Fair Value Measurements  
Fair Value Measurements

Note 15: Fair Value Measurements

Fair Value Measurements Using Fair Value Hierarchy

The Company classifies measurements of fair value within a hierarchy based upon inputs that give the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.

Fair Value of Financial Instruments

Additional information regarding the methods and assumptions used to estimate the fair value of the financial statements can be found in our Annual Report. The following tables show the carrying amounts and estimated fair values of the Company’s financial instruments (dollars in thousands):

Fair Value Measurements at June 30, 2025 using

    

Carrying
Value

    

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

    

Significant
Other
Observable
Inputs
(Level 2)

    

Significant
Unobservable
Inputs
(Level 3)

    

Fair Value

FINANCIAL ASSETS:

Cash and restricted cash

$

11,677

$

11,677

$

$

$

11,677

Loans, net

91,063

88,673

88,673

Investment in joint venture

873

873

873

Other investments

1,096

1,096

1,096

Accrued interest receivable

424

424

424

Servicing assets

179

179

179

FINANCIAL LIABILITIES:

Other secured borrowings

6

6

6

Debt certificates payable

94,620

94,116

94,116

Other financial liabilities

123

123

123

Fair Value Measurements at December 31, 2024 using

    

Carrying
Value

    

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

    

Significant
Other
Observable
Inputs
(Level 2)

    

Significant
Unobservable
Inputs
(Level 3)

    

Fair Value

FINANCIAL ASSETS:

Cash and restricted cash

$

10,771

$

10,771

$

$

$

10,771

Certificates of deposit

1,304

1,308

1,308

Loans, net

93,171

90,684

90,684

Investments in joint venture

873

873

873

Other investments

1,082

1,082

1,082

Accrued interest receivable

447

447

447

Servicing assets

177

177

177

FINANCIAL LIABILITIES:

Other secured borrowings

6

$

$

$

6

$

6

Debt certificates payable

95,073

94,031

94,031

Other financial liabilities

479

479

479

Management uses judgment in estimating the fair value of the Company’s financial instruments; however, there are inherent weaknesses in any estimation technique. Therefore, for substantially all financial instruments, the fair value estimates presented herein are not necessarily indicative of the amounts the Company could have realized in a sales transaction at June 30, 2025 and December 31, 2024.

Fair Value Measured on a Nonrecurring Basis

The Company measures certain assets at fair value on a nonrecurring basis. On these assets, the Company only makes fair value adjustments in certain circumstances (for example, when there is evidence of impairment).

The following table presents the fair value of assets measured on a nonrecurring basis (dollars in thousands):

Fair Value Measurements Using:

    

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

    

Significant
Other
Observable
Inputs
(Level 2)

    

Significant
Unobservable
Inputs
(Level 3)

    

Total

Assets at June 30, 2025:

Collateral-dependent impaired loans (net of allowance and discount)

$

$

$

7,236

$

7,236

Discounted cash flow loans (net of allowance and discount)

7,105

7,105

Investment in joint venture

873

873

Other investments

1,096

1,096

Foreclosed assets (net of allowance)

301

301

Total

$

$

$

16,611

$

16,611

Assets at December 31, 2024:

Collateral-dependent impaired loans (net of allowance and discount)

$

$

$

9,535

$

9,535

Discounted cash flow loans (net of allowance and discount)

7,133

7,133

Investments in joint venture

873

873

Other investments

1,082

1,082

Foreclosed assets (net of allowance)

301

301

Total

$

$

$

18,924

$

18,924

Impaired Loans

The fair value of collateral-dependent impaired loans with specific allocations of the allowance for expected credit losses is generally based on recent real estate appraisals. Such fair values are obtained using independent appraisals, which the Company may discount due to age or other factors, which the Company considers to be Level 3 inputs. The range of these discounts is shown in the table below.

The Company also estimates the fair value of non-collateral-dependent impaired loans using the discounted cash flow method. This method uses estimates of the future cash flows of the loan and discounts those cash flows using the loan’s interest rate.

Foreclosed Assets

At the date of foreclosure, the Company initially records real estate acquired through foreclosure or other proceedings (foreclosed assets) at fair value less estimated costs of disposal, which establishes a new cost. After foreclosure, management periodically performs valuations on foreclosed assets. The company carries foreclosed assets held for sale at the lower of cost or fair value, less estimated costs of disposal. The fair values of real properties initially are determined based on appraisals. In some cases, management adjusts the appraised values for various factors including age of the appraisal, age of comparable properties included in the appraisal, and known changes in the market or in the collateral. The Company makes subsequent valuations of the real properties based either on management estimates or on updated appraisals. If management makes significant adjustments to appraised values based on unobservable inputs, the Company categorizes foreclosed assets under Level 3. Otherwise, if management bases the foreclosed assets’ value on recent appraisals and the only adjustments made are for known contractual selling costs, the Company will categorize the foreclosed assets under Level 2.

Other Investments

Other investments comprise two indexed annuity insurance contracts. The Company measures fair value on its annuity investments on a nonrecurring basis. On these assets, the Company only makes fair value adjustments when there is evidence of impairment. As the principal amounts and recognized income on the annuities is guaranteed, only impairment of the assets would indicate a degradation in their fair value. The Company concluded that no impairment of the annuity investments existed at June 30, 2025 and December 31, 2024. As such, the Company has determined that the carrying value of its other investments equals its fair value at June 30, 2025 and December 31, 2024.

The table below summarizes the valuation methodologies used to measure the fair value adjustments for Level 3 assets recorded at fair value on a nonrecurring basis (dollars in thousands):

June 30, 2025

Assets

    

Fair Value
(in thousands)

    

Valuation
Techniques

    

Unobservable
Input

    

Range
(Weighted Average)

Collateral dependent loans

$

7,236

Discounted appraised value

Selling cost / Estimated market decrease

10% (10%)

Other impaired loans

7,105

Discounted future cash flows

Discount rate

4% (4%)

Investment in joint venture

873

Internal evaluations

Estimated future market value

0% (0%)

Other investments

1,096

Internal evaluations

Indications of non-performance by insurance companies

0% (0%)

Foreclosed Assets

301

Internal evaluations

Selling cost

6% (6%)

December 31, 2024

Assets

    

Fair Value
(in thousands)

    

Valuation
Techniques

    

Unobservable
Input

    

Range
(Weighted Average)

Impaired loans

$

9,535

Discounted appraised value

Selling cost / Estimated market decrease

10% (10%)

Other impaired loans

7,133

Discounted future cash flows

Discount rate

4% (4%)

Investments in joint venture

873

Internal evaluations

Estimated future market value

0% (0%)

Other investments

1,082

Internal evaluations

Indications of non-performance by insurance companies

0% (0%)

Foreclosed assets

301

Internal evaluations

Selling cost

6% (6%)